ClinicalTrials.Veeva

Menu

Using tDCS in Speech-based Stroke Rehabilitation

NYU Langone Health logo

NYU Langone Health

Status

Enrolling

Conditions

Apraxia of Speech

Treatments

Device: Sham
Device: Soterix 1x1 line tDCS low-intensity stimulator

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03452202
17-01474

Details and patient eligibility

About

The purpose of this study is to determine whether the effect of treatment for acquired speech impairment can be enhanced by combining effective behavioral treatment with non-invasive brain stimulation. Transcranial direct current stimulation (tDCS), which delivers low-intensity current to the scalp, and is a safe and well-tolerated approach that poses a non-significant risk to participants. tDCS provides low intensity neural stimulation which has been shown to facilitate motor learning in other domains of stroke rehabilitation such as arm motor learning but the potential to enhance speech motor learning has not been explored. This will be examined with a series of single-case experimental designs.

Enrollment

24 estimated patients

Sex

All

Ages

18 to 99 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Right-handed
  • Monolingual (English)
  • Single left-hemisphere CVA
  • A minimum of six months post-stroke
  • Clinical diagnosis of apraxia of speech
  • Normal speech perception
  • Passing score on the hearing screening.

Exclusion criteria

  • Diagnosis of laryngeal voice disorder
  • Dysarthria
  • History of speech impairment prior to CVA
  • Presence of potential tDCS risk factors: damaged skin at site of stimulation;
  • Presence of electrically or magnetically activated implant (including pacemaker);
  • metal in any part of their body;
  • history of medication-resistant epilepsy in the family;
  • past history of seizures or unexplained spells of loss of consciousness.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

24 participants in 2 patient groups

Active Stimulation
Experimental group
Description:
crossover design such that each participant receives behavioral treatment twice - once with active stimulation and once with sham stimulation - in order to evaluate differences in improvement based on treatment condition.
Treatment:
Device: Soterix 1x1 line tDCS low-intensity stimulator
Device: Sham
Sham Stimulation
Sham Comparator group
Description:
crossover design such that each participant receives behavioral treatment twice - once with active stimulation and once with sham stimulation - in order to evaluate differences in improvement based on treatment condition.
Treatment:
Device: Soterix 1x1 line tDCS low-intensity stimulator
Device: Sham

Trial contacts and locations

2

Loading...

Central trial contact

Buchwald Lab

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems